Kovack Advisors, Inc. Zoetis Inc. Transaction History
Kovack Advisors, Inc.
- $907 Million
- Q1 2025
A detailed history of Kovack Advisors, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Kovack Advisors, Inc. holds 1,379 shares of ZTS stock, worth $217,964. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,379Holding current value
$217,964% of portfolio
0.03%Shares
17 transactions
Others Institutions Holding ZTS
# of Institutions
2,093Shares Held
417MCall Options Held
1.24MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA41.6MShares$6.57 Billion0.13% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$5.82 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.14 Billion0.13% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.53 Billion2.4% of portfolio
-
Morgan Stanley New York, NY11.8MShares$1.87 Billion0.14% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $74B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...